UNITS PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending HIMS's stock price plummeting by over 10%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it could be